Previous studies have shown that noninvasive positive pressure ventilation (NPPV) improves gas exchange in acute and chronic respiratory failure. However, some patients are unable to tolerate NPPV due to air leaks around the mask, facial discomfort, and claustrophobia. A new mask that covers the entire face (Total, Respironics, Monroeville, Pa), attempts to overcome these obstacles. We studied the efficacy of NPPV via the Total face mask (TFM) in nine patients with chronic respiratory failure. In three patients, respiratory failure was due to chronic obstructive lung disease, and in six patients, it was secondary to restrictive disorders. None of the patients were previously able to tolerate NPPV via nasal (N) or nasal-oral (NO) masks. At baseline, all patients had impaired gas exchange with low PaO2/FIo2 (241 ± 14), elevated PaCO2 (79+5 mm Hg), and poor functional status (1.89 ± 1.45, on a scale of 1 to 7). After NPPV in the hospital for 7.1 ± 1.5 h per night for 22 ± 26 days, the PaCO2 fell to 59 ± 3 mm Hg, and the PaO2/FIo2 rose to 304 ± 27. Following nocturnal NPPV via the TFM for 6.7 ± 1.5 h a night 6 ± 5 weeks after hospital discharge, sustained improvements in PaCO2 (58 ± 3 mm Hg, p<0.05), PaO2/FIo2 (304 ± 18), and functional status (5.38±1.06, p<0.05) were observed. In four patients, Noninvasive positive pressure ventilation (NPPV) has been shown to be an effective modality for the treatment of chronic respiratory failure in patients with severe restrictive ventilatory disorders14 and in selected patients with chronic obstructive pulmonary diseases.5 '6 In addition, several recent studies have shown that NPPV may be an effective treatment for acute respiratory failure.7-9 In some patients, however, NPPV has limited efficacy because of significant problems with mask or mouth leaks, the development of facial pressure sores related to the mask, and feelings of claustrophobia.8 '12 Moreover, the requirement for frequent nurse and respiratory therapist intervention to adjust the mask so as to prevent excessive leaking, or ensure patient Our purpose in this study was to compare the short-term effect of NPPV delivered via this total face mask (TFM) to nasal (N) and nasal-oral (NO) masks, on ventilatory variables, gas exchange, dyspnea, mouth and mask leaks, and patient comfort with the mask. In addition, we wanted to determine the long-term efficacy of daily nocturnal NPPV via the TFM on gas exchange and functional status after several weeks.
Herein, we discuss the effectiveness of NPPV with this TFM in the treatment of patients with chronic respiratory failure. 
METHODS
Patient Selection All patients were admitted to the Ventilator Rehabilitation Unit at Temple University Hospital, Philadelphia, for evaluation and treatment of chronic respiratory failure. This noninvasive respiratory care unit evaluates patients for noninvasive mechanical ventilation, instructs patients in the use of respiratory equipment, provides whole body and respiratory muscle reconditioning, and coordinates continuing outpatient follow-up.
Prior to admission all patients were maximally treated with bronchodilators, supplemental oxygen, and on occasion theophylline for at least 48 h prior to study enrollment. All patients enrolled into the study fulfilled at least two clinical criteria and two physiologic criteria for implementation of noninvasive ventilation as shown in Table 1 5=ambulatory, but homebound; 6=performs non-self-care activities at home (ie, cooking, housework, etc); and 7=performs activities outside of home.
The patient's level of discomfort with the face mask was scaled as follows: O=comfortable, l=uncomfortable, and 2=very uncomfortable.
The level of dyspnea was scored in arbitrary units with a fourpoint scale: O=no dyspnea; l=mild dyspnea; 2=moderate dyspnea; and 3=severe dyspnea.
The degree of air leakage for each mask was also scaled with a four-point scale using arbitrary units: O=no leaks; 1=one to three leaks per minute; 2=three to six leaks per minute; and 3=greater than six leaks per minute.
Experimental Protocols
Comparative Efficacy of the Various Masks During Shortterm NPPV: Baseline measurements of ventilatory variables (ie, minute ventilation, tidal volume, respiratory rate), and arterial blood gas tensions were performed in four patients during eupneic ventilation. All patients then underwent three NPPV trials of 20 to 30 min duration to ensure stability during noninvasive ventilation using each of the three different masks (TFM, N, NO) in random order. After initial titration of pressure (BiPAP) or volume (PLV-102), to achieve ventilation goals as previously outlined, levels of ventilation remained identical during each trial with the three different face masks. At the end of each trial, arterial blood gas analysis was performed and the patients were queried with regard to their level of comfort with the mask, and their perception of dyspnea when using each of the masks. In addition, a semiquantitative analysis of air leaks during NPPV with each mask was determined. Long-term Efficacy of NPPV via the TFM: In nine patients, NPPV was delivered via the TFM as an inpatient for 22 + 26 days, 7.1 + 1.5 h a night, and as an outpatient for 6 + 5 weeks, 6.7 + 1.5 h a night. Arterial blood gases and functional status were measured at admission, discharge from the hospital, and at follow-up. Respiratory mechanics (spirometry and respiratory muscle pressures) were also obtained in follow-up.
Statistical Analysis
An analysis of variance was used to compare ventilatory variables, arterial blood gases, mask leaks, discomfort with the face mask and level of dyspnea between eupnea, and NPPV via the various masks. The Student's t test was used to determine whether a significant relationship existed between the values for arterial blood gases, respiratory mechanics, and functional status at baseline, hospital discharge, and follow-up. A p value <0.05 was considered statistically significant.
RESULTS
Patient characteristics are shown in Table 2 . Three patients had severe obstructive lung disease, and six patients had severe restrictive disorders. The patients' ages ranged from 44 to 81 years. Three of the nine patients suffered from acute superimposed on chronic respiratory failure that had necessitated recent (within 6 months of the study) endotracheal intubation and mechanical ventilation. The remaining patients had a more gradual, progressive worsening of their respiratory status. Five patients had evidence of cor pulmonale with a right-sided third heart sound, elevation in the pulmonic component of the second heart sound, peripheral edema, and evidence of right ventricular dysfunction by two-dimension echocardiography. All patients had severe derangements in lung mechanics with an FVC (mean ± SD) of 0.95±0.44 L, and FEV1 of 0.57 ±0.18 L.
Comparative Efficacy of the Various Masks During Short-term NPPV Arterial blood gas analysis for each patient while breathing spontaneously and during NPPV with each of the three masks is shown in Figure 2 tient is shown in Table 3 . Respiratory rate tended on average to be lower during NPPV compared with eupnea, but was not statistically significant. Expired minute volumes were also greatest with NPPV when compared with eupnea, but not different among the three masks. Expired tidal volumes were significantly greater with NPPV when compared with eupnea (p<0.05), and the exhaled tidal volume was greatest with the TFM (p<0.05). Inspired tidal volumes, inspiratory time and mean inspiratory flow, and duty cycle were significantly increased with the use of NPPV, when compared with eupnea (Table 3) . Among the three masks, the duty cycle was least with the TFM (p<0.05). Figure 3 shows the degree of air leaks and the levels of discomfort with the face mask and dyspnea among the three masks in NPPV. There was a significant reduction (p<0.003) in air leakage when NPPV was delivered via the TFM (0.44 ± 0.18) when compared with the N (1.89 ± 0.39) and NO masks (1.89 ± 0.35). The level of discomfort with the NPPV face mask was also least with the TFM (p<0.02). Finally, dyspnea was also significantly less in NPPV with the TFM (p<0.02) and N mask (p<0.05) in comparison to eupnea and NPPV with the NO mask. 
Because the TFM covers the entire face, one would think that this would worsen feelings of claustrophobia rather than improve it. However, in three patients in whom claustrophobia limited tolerance of the NO mask, this sensation was avoided with the use of the TFM. Potential explanations for the reduction in claustrophobia while using the TFM include the following: an unobstructed patient field of vision; the ability to verbally communicate; and the sensation of air flowing over the entire face while using the mask. Conceivably, allowing the patients to see and verbally communicate while in the TFM may have lessened the patient's feelings of isolation, and further improved the patient's tolerance of noninvasive ventilation.
Many patients with pulmonary conditions express a subjective decrease in the sensation of dyspnea when cold or flowing air is directed to the face. Breathless patients commonly request a fan or to be placed near an open window to alleviate breathlessness. Schwartzstein et al'4 have shown a significant reduction in the sensation of dyspnea when normal subjects have cold air directed to the cheeks while breathing against an inspiratory resistive load. DiGiorgio and Giulio showed similar r'esults in normal subjects breathing through a range of linear resistive loads from 1.5 to 15 cm H20 when ambient air produced by a fan was applied to the subject's face. '15"6 Although, the mechanism(s) responsible for the reductions in dyspnea when cold or ambient air is directed to the face are unknown, Schwartzstein and colleagues14 hypothesized that stimulation of afferent trigeminal nerve receptors may have altered the central perception of breathlessness. It is conceivable that stimulating facial cutaneous receptors via continuous airflow during NPPV via the TFM may have contributed in part to a reduction in the patient's sensation of dyspnea while using this mask. Whatever the mechanism(s), however, all patients reported the greatest reduction in dyspnea during noninvasive ventilation when using the TFM.
Complications that arose using the TFM ventilation were minimal. Since this form of face mask has a much larger volume, it has a significantly greater amount of dead space compared with other commercially available forms of N or NO masks. The dead space volume of the TFM is 1,500 ml, compared with 105 ml with the N mask and 250 ml with the NO mask (not accounting for a reduction in dead space by facial structures when wearing the mask). However, in no patient did this increased amount of dead space pose a problem by either increasing the patient's sense of dyspnea or adversely affecting blood gas tensions.
To minimize the potentially adverse effects of an increased dead space with the full face mask, the manufacturer recommends a base flow sufficient to maintain an expiratory positive airway pressure of 4 or 5 cm H20 at all times. In addition, there are two small bore orifices in the superior aspect of the mask to act as exhalation valves. In patients discharged home from the hospital with the mask, oxygen was administered by a compressed gas source to ensure gas flow if electrical failure would occur. Moreover, all masks were equipped with quick release straps to ensure immediate removal if needed. All of our patients were awake and alert, were able to provide their own self-care, and were knowledgeable about the benefits and potential hazards of using a TFM. We followed the above-stated recommendations and found in all patients while using this mask a reduction in the sense of dyspnea, a lowering in the arterial carbon dioxide, and an improvement in their functional status. No complications during short-or long-term use at home were observed in our patients, and the above recommendations for use are strongly encouraged.
Other complications such as eye irritation and gastric distention would be expected to be more common during noninvasive ventilation with the TFM. However, eye irritation and gastric distention were not observed in any subject and may further reflect an improvement in patient ventilator synchrony with the use of a more comfortable mask.
Although NPPV via N, oral, or NO routes has been shown to be effective in improving ventilatory status in patients with acute or chronic respiratory failure, these therapies are limited by being labor intensive. When noninvasive ventilation is applied to critically ill patients with acute respiratory failure, mask leaks, patient communication, and patient comfort necessitate constant nursing and/or respiratory therapy intervention for mask repositioning and patient monitoring. Chevrolet and colleagues"l reported that patients with COPD receiving NPPV required 90 to 100 percent of one ICU nurse's time to provide emotional support, give direct personal care, and adjust the face mask. These constant demands on nursing care and mask repositioning limit the broad application of this technique for patients in acute respiratory failure. A face mask that is more comfortable for the patient but requires less adjustment to minimize mask'or mouth leaks could substantially reduce the labor intensiveness of NPPV.
Mask or mouth' leaks may also have a negative effect on gas exchange and impair the effectiveness of NPPV in avoiding endotracheal intubation. In studies examining NPPV in acute respiratory failure, inability to improve gas exchange, or poor patient tolerance of the mask, results in 10 to 50 percent of pa- tients failing therapy and requiring endotracheal intubation.79,11,12 Improvements in face mask design that improve patient tolerance and increase alveolar ventilation by minimizing leaks may have a significant impact on NPPV being successful in patients with acute respiratory failure. Recently, in two of our patients, noninvasive ventilation with the TFM was used in the ICU when the patients originally presented in acute respiratory failure. Although, N and NO masks were poorly tolerated by these two patients because of feelings of claustrophobia, significant mouth leaks, and patient-ventilation dyssynchrony, noninvasive ventilation via the TFM was easily applied, was well tolerated by the patients, and was not complicated by significant leaks even when used for extended periods of time (ie, continuously for 10 to 12 h). In one of the two patients, noninvasive ventilation via the TFM was possible despite the presence of a nasogastric tube for administration of medications without adversely affecting the patient mask seal.
In summary, we have shown that NPPV via a TFM in selected patients with chronic respiratory failure may improve comfort, minimize air leakage from the mask-face interface, and improve alveolar ventilation. Furthermore, we suggest that this form of mask may be effective in patients suffering from acute respiratory failure who are candidates for noninvasive mechanical ventilation in a controlled environment such as the ICU. As our data show, the face mask used for noninvasive ventilation may have an important impact on the degree of face mask or mouth leaks, patient tolerance, and overall efficacy of noninvasive ventilation. Additional larger, prospective, and randomized clinical trials using the various forms of face masks are currently needed to confirm the most effective mask for delivering NPPV.
